Home Procurement NewsDrugmaker Gilead to acquire CymaBay for $4.3 billion

Drugmaker Gilead to acquire CymaBay for $4.3 billion

February 12, 2024•

The deal will give Gilead access to CymaBay’s lead drug candidate called seladelpar, adding a treatment for chronic liver disease to its portfolio.

Was this article helpful?

YesNo

Last modified: February 12, 2024

Previous: Alleged Procurement Fraud: EFCC Opens Case Against Emefiele

Next: Labour Party Crisis: Treasurer Asks Julius Abure To Account For N3.5 Billion

Are you ready to join the Community?

Join the Conversation!

Community of Practice Portal aims to bring together key stakeholders in the procurement landscape in Nigeria to leverage on each others skillset in relation to understanding Procurement data in a bid to use these data to create stories and to generate action from the government.

Community of practice platform is an initiative under Anti-Corruption Innovation Project, a UNDP funded Project in collaboration with Accountability lab Nigeria, and Open Contracting Partnerships